To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/10373/251904_9ea3c480f4166aa2_001full.jpg "My family has a history of ...
Observational data suggested that men with nonmetastatic prostate cancer lived longer if they followed a healthier lifestyle. A higher prostate cancer behavior score was associated with reductions in ...
A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of ...
TORONTO, June 10, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (PROF) (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets ...
Screening men for prostate cancer would save thousands of lives by slashing their risk of dying from the disease by 13 per cent, a major study reveals. Testing led to a ‘sustained reduction’ in deaths ...
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. PSA is one of the most widely used and ...
Each 1-point increase in the 2021 Prostate Cancer Behavior Score was significantly associated with a reduction in all-cause mortality. Healthy lifestyle and dietary choices are associated with a ...
Non-cancer causes of death in patients with hormone-sensitive prostate cancer. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary Cancers Symposium. This abstract does not include a ...
Expanded indication for AKEEGA® (niraparib and abiraterone acetate dual-action tablet) plus prednisone marks the first FDA-approved precision medicine combination treatment for patients with ...
Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26 ...
Men with nonmetastatic prostate cancer lived longer if they followed a healthier lifestyle, despite no reduction in prostate cancer-specific mortality, according to a large observational study. A ...